Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 332

1.

Early life social and ecological determinants of global DNA methylation in wild spotted hyenas.

Laubach ZM, Faulk CD, Dolinoy DC, Montrose L, Jones TR, Ray D, Pioon MO, Holekamp KE.

Mol Ecol. 2019 Aug;28(16):3799-3812. doi: 10.1111/mec.15174. Epub 2019 Aug 12.

PMID:
31291495
2.

Evidence of Isotopic Fractionation During Vapor Exchange Between the Atmosphere and the Snow Surface in Greenland.

Madsen MV, Steen-Larsen HC, Hörhold M, Box J, Berben SMP, Capron E, Faber AK, Hubbard A, Jensen MF, Jones TR, Kipfstuhl S, Koldtoft I, Pillar HR, Vaughn BH, Vladimirova D, Dahl-Jensen D.

J Geophys Res Atmos. 2019 Mar 27;124(6):2932-2945. doi: 10.1029/2018JD029619. Epub 2019 Mar 18.

3.

Somatic expression of piRNA and associated machinery in the mouse identifies short, tissue-specific piRNA.

Perera BPU, Tsai ZT, Colwell ML, Jones TR, Goodrich JM, Wang K, Sartor MA, Faulk C, Dolinoy DC.

Epigenetics. 2019 May;14(5):504-521. doi: 10.1080/15592294.2019.1600389. Epub 2019 Apr 8.

PMID:
30955436
4.

Persistence and 4-year boosting of the bactericidal response elicited by two- and three-dose schedules of MenB-FHbp: A phase 3 extension study in adolescents.

Vesikari T, Østergaard L, Beeslaar J, Absalon J, Eiden JJ, Jansen KU, Jones TR, Harris SL, Maansson R, Munson S, O'Neill RE, York LJ, Perez JL.

Vaccine. 2019 Mar 14;37(12):1710-1719. doi: 10.1016/j.vaccine.2018.11.073. Epub 2019 Feb 12.

PMID:
30770221
5.

Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults.

Schmoele-Thoma B, van Cleeff M, Greenberg RN, Gurtman A, Jones TR, Sundaraiyer V, Gruber WC, Scott DA.

Hum Vaccin Immunother. 2019;15(3):575-583. doi: 10.1080/21645515.2018.1538618. Epub 2019 Jan 16.

6.

Electronic prescribing: introducing a stat optional dose to improve time to antibiotic on the acute medical unit.

Jones TRE, Nurse K.

BMJ Open Qual. 2018 Dec 19;7(4):e000292. doi: 10.1136/bmjoq-2017-000292. eCollection 2018.

7.

LINE-1 and EPAS1 DNA methylation associations with high-altitude exposure.

Childebayeva A, Jones TR, Goodrich JM, Leon-Velarde F, Rivera-Chira M, Kiyamu M, Brutsaert TD, Dolinoy DC, Bigham AW.

Epigenetics. 2019 Jan;14(1):1-15. doi: 10.1080/15592294.2018.1561117. Epub 2019 Jan 9.

PMID:
30574831
8.

The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci.

Harris SL, Tan C, Andrew L, Hao L, Liberator PA, Absalon J, Anderson AS, Jones TR.

Vaccine. 2018 Oct 29;36(45):6867-6874. doi: 10.1016/j.vaccine.2018.05.081. Epub 2018 Sep 27.

PMID:
30269916
9.

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort.

Qin T, Zhang Y, Zarins KR, Jones TR, Virani S, Peterson LA, McHugh JB, Chepeha D, Wolf GT, Rozek LS, Sartor MA.

Sci Rep. 2018 Jul 30;8(1):11458. doi: 10.1038/s41598-018-29599-w.

10.

From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine.

Perez JL, Absalon J, Beeslaar J, Balmer P, Jansen KU, Jones TR, Harris S, York LJ, Jiang Q, Radley D, Anderson AS, Crowther G, Eiden JJ.

Expert Rev Vaccines. 2018 Jun;17(6):461-477. doi: 10.1080/14760584.2018.1483726. Epub 2018 Jun 22. Review.

PMID:
29883226
11.

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.

McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS.

MBio. 2018 Mar 13;9(2). pii: e00036-18. doi: 10.1128/mBio.00036-18.

12.

Southern Hemisphere climate variability forced by Northern Hemisphere ice-sheet topography.

Jones TR, Roberts WHG, Steig EJ, Cuffey KM, Markle BR, White JWC.

Nature. 2018 Feb 15;554(7692):351-355. doi: 10.1038/nature24669. Epub 2018 Feb 5.

PMID:
29400700
13.

A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.

Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Prégaldien JL, Ginis J, Staerke NB, Perez JL; B1971009 and B1971016 Trial Investigators.

N Engl J Med. 2017 Dec 14;377(24):2349-2362. doi: 10.1056/NEJMoa1614474.

14.

SigTree: A Microbial Community Analysis Tool to Identify and Visualize Significantly Responsive Branches in a Phylogenetic Tree.

Stevens JR, Jones TR, Lefevre M, Ganesan B, Weimer BC.

Comput Struct Biotechnol J. 2017 Jul 6;15:372-378. doi: 10.1016/j.csbj.2017.06.002. eCollection 2017. Review.

15.

A Proposed Model for Perinatal Palliative Care.

Cole JCM, Moldenhauer JS, Jones TR, Shaughnessy EA, Zarrin HE, Coursey AL, Munson DA.

J Obstet Gynecol Neonatal Nurs. 2017 Nov - Dec;46(6):904-911. doi: 10.1016/j.jogn.2017.01.014. Epub 2017 Jun 8.

PMID:
28602660
16.

Bactericidal activity of sera from adolescents vaccinated with bivalent rLP2086 against meningococcal serogroup B outbreak strains from France.

Taha MK, Hawkins JC, Liberator P, Deghmane AE, Andrew L, Hao L, Jones TR, McNeil LK, O'Neill RE, Perez JL, Jansen KU, Anderson AS.

Vaccine. 2017 Mar 13;35(11):1530-1537. doi: 10.1016/j.vaccine.2017.01.066. Epub 2017 Feb 10.

PMID:
28196734
17.

Meningococcal serogroup B vaccines: Estimating breadth of coverage.

Donald RG, Hawkins JC, Hao L, Liberator P, Jones TR, Harris SL, Perez JL, Eiden JJ, Jansen KU, Anderson AS.

Hum Vaccin Immunother. 2017 Feb;13(2):255-265. doi: 10.1080/21645515.2017.1264750. Epub 2016 Dec 14. Review.

18.

Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak Strains.

Harris SL, Donald RG, Hawkins JC, Tan C, O'Neill R, McNeil LK, Perez JL, Anderson AS, Jansen KU, Jones TR.

Pediatr Infect Dis J. 2017 Feb;36(2):216-223. doi: 10.1097/INF.0000000000001399.

PMID:
27846061
19.

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial.

Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee SS, Perez JL; 6108A12001 Study Investigators.

Lancet Infect Dis. 2017 Jan;17(1):58-67. doi: 10.1016/S1473-3099(16)30314-0. Epub 2016 Oct 11.

PMID:
27745812
20.

Lipid metabolism is associated with developmental epigenetic programming.

Marchlewicz EH, Dolinoy DC, Tang L, Milewski S, Jones TR, Goodrich JM, Soni T, Domino SE, Song PX, F Burant C, Padmanabhan V.

Sci Rep. 2016 Oct 7;6:34857. doi: 10.1038/srep34857.

21.

Impact of Standardized New Medication Education Program on Postdischarge Patients' Knowledge and Satisfaction.

Jones TR, Coke L.

J Nurs Adm. 2016 Oct;46(10):535-40. doi: 10.1097/NNA.0000000000000398.

PMID:
27681515
22.

Bisphenol A-associated alterations in genome-wide DNA methylation and gene expression patterns reveal sequence-dependent and non-monotonic effects in human fetal liver.

Faulk C, Kim JH, Jones TR, McEachin RC, Nahar MS, Dolinoy DC, Sartor MA.

Environ Epigenet. 2015 Dec;1(1). pii: dvv006. Epub 2015 Jan 1.

23.

Restaurant Cooking Trends and Increased Risk for Campylobacter Infection.

Jones AK, Rigby D, Burton M, Millman C, Williams NJ, Jones TR, Wigley P, O'Brien SJ, Cross P; ENIGMA Consortium.

Emerg Infect Dis. 2016 Jul;22(7):1208-15. doi: 10.3201/eid2207.151775.

24.

Detection of differential DNA methylation in repetitive DNA of mice and humans perinatally exposed to bisphenol A.

Faulk C, Kim JH, Anderson OS, Nahar MS, Jones TR, Sartor MA, Dolinoy DC.

Epigenetics. 2016 Jul 2;11(7):489-500. doi: 10.1080/15592294.2016.1183856. Epub 2016 Jun 6.

26.

Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.

Senders S, Bhuyan P, Jiang Q, Absalon J, Eiden JJ, Jones TR, York LJ, Jansen KU, O'Neill RE, Harris SL, Ginis J, Perez JL.

Pediatr Infect Dis J. 2016 May;35(5):548-54. doi: 10.1097/INF.0000000000001072.

PMID:
26835974
27.

Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents.

Vesikari T, Wysocki J, Beeslaar J, Eiden J, Jiang Q, Jansen KU, Jones TR, Harris SL, O'Neill RE, York LJ, Perez JL.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):180-7. doi: 10.1093/jpids/piv064. Epub 2016 Jan 23.

28.

Immunogenicity, safety, and tolerability of the meningococcal serogroup B bivalent rLP2086 vaccine in adult laboratory workers.

Reiner DM, Bhuyan P, Eiden JJ, Ginis J, Harris S, Jansen KU, Jiang Q, Jones TR, O'Neill RE, York LJ, Perez JL.

Vaccine. 2016 Feb 3;34(6):809-13. doi: 10.1016/j.vaccine.2015.12.016. Epub 2015 Dec 19.

PMID:
26707218
29.

Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents.

Vesikari T, Østergaard L, Diez-Domingo J, Wysocki J, Flodmark CE, Beeslaar J, Eiden J, Jiang Q, Jansen KU, Jones TR, Harris SL, O'Neill RE, York LJ, Crowther G, Perez JL.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):152-60. doi: 10.1093/jpids/piv039. Epub 2015 Aug 4.

30.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine.

Bryant KA, Frenck R, Gurtman A, Rubino J, Treanor J, Thompson A, Jones TR, Sundaraiyer V, Baxter LM, Gruber WC, Emini EA, Scott DA, Schmoele-Thoma B.

Vaccine. 2015 Oct 26;33(43):5854-5860. doi: 10.1016/j.vaccine.2015.08.080. Epub 2015 Sep 9.

PMID:
26362099
31.

Saturated Reconstruction of a Volume of Neocortex.

Kasthuri N, Hayworth KJ, Berger DR, Schalek RL, Conchello JA, Knowles-Barley S, Lee D, Vázquez-Reina A, Kaynig V, Jones TR, Roberts M, Morgan JL, Tapia JC, Seung HS, Roncal WG, Vogelstein JT, Burns R, Sussman DL, Priebe CE, Pfister H, Lichtman JW.

Cell. 2015 Jul 30;162(3):648-61. doi: 10.1016/j.cell.2015.06.054.

32.

Macrocyclic Oligoesters Incorporating a Cyclotetrasiloxane Ring.

Frampton MB, Marquardt D, Jones TR, Harroun TA, Zelisko PM.

Biomacromolecules. 2015 Jul 13;16(7):2091-100. doi: 10.1021/acs.biomac.5b00518. Epub 2015 Jun 25.

PMID:
26061086
33.

In search of multimodal neuroimaging biomarkers of cognitive deficits in schizophrenia.

Sui J, Pearlson GD, Du Y, Yu Q, Jones TR, Chen J, Jiang T, Bustillo J, Calhoun VD.

Biol Psychiatry. 2015 Dec 1;78(11):794-804. doi: 10.1016/j.biopsych.2015.02.017. Epub 2015 Feb 24.

34.

Large-scale automatic reconstruction of neuronal processes from electron microscopy images.

Kaynig V, Vazquez-Reina A, Knowles-Barley S, Roberts M, Jones TR, Kasthuri N, Miller E, Lichtman J, Pfister H.

Med Image Anal. 2015 May;22(1):77-88. doi: 10.1016/j.media.2015.02.001. Epub 2015 Mar 2.

35.

The discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.

Zlotnick GW, Jones TR, Liberator P, Hao L, Harris S, McNeil LK, Zhu D, Perez J, Eiden J, Jansen KU, Anderson AS.

Hum Vaccin Immunother. 2015;11(1):5-13. doi: 10.4161/hv.34293. Epub 2014 Nov 1. Review.

36.

Pipeline for illumination correction of images for high-throughput microscopy.

Singh S, Bray MA, Jones TR, Carpenter AE.

J Microsc. 2014 Dec;256(3):231-6. doi: 10.1111/jmi.12178. Epub 2014 Sep 16.

37.

A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.

Macintyre CR, Ridda I, Gao Z, Moa AM, McIntyre PB, Sullivan JS, Jones TR, Hayen A, Lindley RI.

PLoS One. 2014 Apr 23;9(4):e94578. doi: 10.1371/journal.pone.0094578. eCollection 2014.

38.

Perinatal bisphenol A exposure promotes dose-dependent alterations of the mouse methylome.

Kim JH, Sartor MA, Rozek LS, Faulk C, Anderson OS, Jones TR, Nahar MS, Dolinoy DC.

BMC Genomics. 2014 Jan 17;15:30. doi: 10.1186/1471-2164-15-30.

39.

Comparison of methods for image-based profiling of cellular morphological responses to small-molecule treatment.

Ljosa V, Caie PD, Ter Horst R, Sokolnicki KL, Jenkins EL, Daya S, Roberts ME, Jones TR, Singh S, Genovesio A, Clemons PA, Carragher NO, Carpenter AE.

J Biomol Screen. 2013 Dec;18(10):1321-9. doi: 10.1177/1087057113503553. Epub 2013 Sep 17.

40.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

Jackson LA, Gurtman A, Rice K, Pauksens K, Greenberg RN, Jones TR, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

Vaccine. 2013 Aug 2;31(35):3585-93. doi: 10.1016/j.vaccine.2013.05.010. Epub 2013 May 18.

41.

Stability of within-host-parasite communities in a wild mammal system.

Knowles SC, Fenton A, Petchey OL, Jones TR, Barber R, Pedersen AB.

Proc Biol Sci. 2013 May 15;280(1762):20130598. doi: 10.1098/rspb.2013.0598. Print 2013 Jul 7.

42.

A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults.

Marshall HS, Richmond PC, Nissen MD, Wouters A, Baber J, Jiang Q, Anderson AS, Jones TR, Harris SL, Jansen KU, Perez JL.

Vaccine. 2013 Mar 15;31(12):1569-75. doi: 10.1016/j.vaccine.2013.01.021. Epub 2013 Jan 24.

PMID:
23352429
43.

Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease.

Anderson AS, Hao L, Jiang Q, Harris SL, Jones TR, Perez JL, York L, Eiden J, Jansen KU.

Hum Vaccin Immunother. 2013 Mar;9(3):471-9. Epub 2012 Dec 18.

44.

A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents.

Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, Jansen KU, Perez JL.

Pediatr Infect Dis J. 2013 Apr;32(4):364-71. doi: 10.1097/INF.0b013e31827b0d24.

45.

A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial.

Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, Gruber WC, Jones TR, Arora A.

Vaccine. 2012 Sep 21;30(43):6163-74. doi: 10.1016/j.vaccine.2012.07.065. Epub 2012 Aug 5.

PMID:
22871351
46.

Safety and immunogenicity of a meningococcal B bivalent rLP2086 vaccine in healthy toddlers aged 18-36 months: a phase 1 randomized-controlled clinical trial.

Marshall HS, Richmond PC, Nissen MD, Jiang Q, Anderson AS, Jansen KU, Reynolds G, Ziegler JB, Harris SL, Jones TR, Perez JL.

Pediatr Infect Dis J. 2012 Oct;31(10):1061-8.

PMID:
22718089
47.

Delivery type not associated with global methylation at birth.

Virani S, Dolinoy DC, Halubai S, Jones TR, Domino SE, Rozek LS, Nahar MS, Padmanabhan V.

Clin Epigenetics. 2012 Jun 9;4(1):8. doi: 10.1186/1868-7083-4-8.

48.

Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.

Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators.

Lancet Infect Dis. 2012 Aug;12(8):597-607. Epub 2012 May 7.

PMID:
22569484
49.

Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A.

Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, Weinhouse C, Rozek LS, Dolinoy DC.

Environ Mol Mutagen. 2012 Jun;53(5):334-42. doi: 10.1002/em.21692. Epub 2012 Mar 29.

50.

Two conscientious guinea pigs: A participant student view of the conscientiousness index.

Cox DR, Jones TR.

Med Teach. 2012;34(1):65-7. doi: 10.3109/0142159X.2011.579646. No abstract available.

PMID:
22250677

Supplemental Content

Loading ...
Support Center